Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Wall Street
Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
REGN
is 862.4 USD
with a low forecast of 666.6 USD and a high forecast of 1 109.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is REGN's stock price target?
Price Target
862.4
USD
According to Wall Street analysts, the average 1-year price target for
REGN
is 862.4 USD
with a low forecast of 666.6 USD and a high forecast of 1 109.85 USD.
What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
9%
For the last 14 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's revenue is
28%.
The projected
CAGR
for the next 3 years is
9%.
What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
23%
The
compound annual growth rate
of Regeneron Pharmaceuticals Inc's operating income for the next 3 years is
23%.
What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Regeneron Pharmaceuticals Inc's net income for the next 3 years is
13%.
